programme of research
University of Sheffield
2005/6
DIVISION OF GENOMIC MEDICINE
YCR Director of Cancer Research: Professor B W Hancock
SECTION OF ONCOLOGY & PATHOLOGY
(YCR Institute for Cancer Studies, Academic Unit of Clinical Oncology, Academic Unit of Pathology)
YCR Institute for Cancer Studies
A. Cox
The effect of single nucleotide polymorphisms on clinical outcome and survival in the FOCUS clinical trial of metastatic colorectal cancer.
T. Helleday
Molecular mechanism for genetic instability caused by inactivation of poly (ADP-ribose) polymerase.
M. Meuth
Genetic Instability and Cancer.
C.M. Sanders
A structural investigation of the papillomavirus replication initiation complexes.
Academic Unit of Pathology
C. Lewis
Development of a macrophage-based system to target therapeutic viruses to prostate cancer.
C. Lewis
Novel use of hypoxia response promoters in Salmonella to target genes to hypoxic.
Academic Unit of Infection and Immunity
A. Heath
Novel, highly immunogenic ganglioside based cancer vaccines.
A. Heath
J. Cariring
Improved idiotype vaccines for cancer.
Division of Clinical Sciences (S)
Academic Unit of Urology
C.L. Eaton
The role of Osteoprotegerin on prostate cancer survival.
Academic Unit of Surgical Oncology
C.A. Staton
The relationship between tissue factor and vascular endothelial growth factor in breast cancer.
Medical Imaging and Medical Physics
W.B. Tindale
FDG dual-headed PET identifies those patients with non-small cell lung cancer who are suitable for surgery?
Department of Biomedical Science
P.W. Andrews
A screen of candidate regulatory genes that may play a role in the progression of testicular germ cell tumours.
P.W. Andrews
Regulation of pluripotency in malignant stem cells.
|